Biora, with spin on Xeljanz nearing the clinic, posts data on its targeted gut drug delivery device

Biora Therapeutics has generated more evidence that the delivery device behind its spin on Xeljanz can get drugs safely to targets in the gut, regardless of whether the recipient is fed or fasted.